MetAlert Inc. (MLRT) Announces Canadian Distributor Launch of Award-Winning 4G GPS SmartSole Medical Monitoring Device for Alzheimer’s, Dementia, and Autism

  • ARPA-H is investing a billion dollars to encourage cutting-edge research for Alzheimer’s, supporting bold ideas to pursue and drive new biomedical breakthroughs
  • The Department of Health and Human Services is investing in research and technology to help keep Alzheimer’s patients in their homes longer, train caregivers to support them, and educate Americans about Alzheimer’s early warning signs – all of which MetAlert provides products and solutions for
  • The Alzheimer’s Disease diagnostic and therapeutic market is expected to reach an estimated $9.6 billion by 2027

MetAlert (OTC: MLRT), a pioneer in location-sensitive health monitoring devices and wearable technology products, has announced that Canadian distributor Red Dot Alerts has launched the new award-winning 4G GPS SmartSole – a wearable medical monitoring device integrated into the orthotic insole allowing for discreet tracking and remote monitoring for those with Alzheimer’s, dementia, and autism (https://ibn.fm/NSPZ4).

The launch is supported by a marketing and advertising campaign, including radio ads, magazine ads, and mailers to medical clinics, hospitals, pharmacies, and senior residence facilities across Canada. The advertising campaign will continue into Spring 2023, coinciding with Canada’s Fall Prevention Month in…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to MLRT are available in the company’s newsroom at https://ibn.fm/MLRT

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.